[AXN] Aoxing Pharmaceutical Company, Inc.

Overview

Type of security: Stock

Sector: Health Care

Industry: Major Pharmaceuticals

Market Capitalization:

Exchange: AMEX

The data is delayed by 15 minutes.

 

Price: 0.34 Change: -0.02 (-4.42%)
Ext. hours: Change: 0 (0%)

chart AXN

Refresh chart

Description: Aoxing Pharmaceutical Company, Inc., a specialty pharmaceutical company, researches, develops, manufactures, and distributes various narcotic, pain-management, and addiction treatment pharmaceutical products primarily in the People?s Republic of China. The company?s principal products comprise Zhongtongan, a capsule of herbal extraction for the indication of oral and dental pain; and Bismuth Potassium Citrate, an oral solution for the treatment of chronic gastritis and stomachache due to excessive stomach acid. Its principal products under development include Tilidine hydrochloride, which is under production preparation and is intended for the treatment of severe pain and chronic cancer-related pain; Codeine Phosphate Compound oral solution that is under review phase and is intended for the treatment of cold and flu; Buprenorphine/Naloxone, which is intended for the treatment of opioid dependence; and Oxycodone and Acetaminophen tablets and compound capsules, which are clinical development to cure acute and c

See how to gain 20% in 14 sec with TrendsInvesting

Fundamental Ratios
Shares Outstanding EPS-0.02 EPS Growth - 4 Quarters EPS Growth - Q/Q
EPS Growth - Y/Y Sales Growth - 4 Quarters 104.03% Sales Growth - Q/Q3.76% P/E-16.5
P/E To EPS Growth P/S P/BV Price/Cash Per Share
Price/Free Cash Flow ROA-2.15% ROE-24.33% ROI
Current Ratio0.46 Quick Ratio0.41 Long Term Debt/Equity-0.28 Debt Ratio8.89
Gross Margin73.35% Operating Margin21.95% Net Profit Margin-4.78% Dividend Payout Ratio
Dividend Yield
Fundamental Data
Cash From Financing Activities270 K Cash From Investing Activities-3.01 M Cash From Operating Activities5.15 M Gross Profit5.51 M
Net Profit780 K Operating Profit2.09 M Total Assets46.25 M Total Current Assets16.85 M
Total Current Liabilities36.38 M Total Debt32.4 M Total Liabilities40.75 M Total Revenue6.59 M
Technical Data
High 52 week0.59 Low 52 week0.11 Last close0.12 Last change0%
RSI19.67 Average true range0.05 Beta0.03 Volume112.5 K
Simple moving average 20 days-13.15% Simple moving average 50 days-43.79% Simple moving average 200 days-63.89%
Performance Data
Performance Week1.5% Performance Month-51.28% Performance Quart-58% Performance Half-67.95%
Performance Year-70.66% Performance Year-to-date-61.95% Volatility daily21.29% Volatility weekly47.61%
Volatility monthly97.57% Volatility yearly337.99% Relative Volume121.18% Average Volume280.73 K
New High New Low

News

2017-10-18 19:11:31 | Should You Invest In The Healthcare Stock Aoxing Pharmaceutical Company Inc AXN?

2017-10-04 11:16:17 | How Does Investing In Aoxing Pharmaceutical Company Inc AXN Impact Your Portfolio?

2017-09-25 06:00:00 | Aoxing Pharmaceutical Announces Delisting and Deregistration of Common Stock

2017-09-19 10:51:11 | Should You Be Holding Aoxing Pharmaceutical Company Inc AXN Right Now?

2017-05-26 09:19:20 | Aoxing Pharmaceutical Co., Inc. :AXN-US: Earnings Analysis: Q3, 2017 By the Numbers : May 26, 2017

2017-05-15 16:30:00 | Aoxing Pharmaceutical Reports Q3 Fiscal 2017 Financial Results

2017-05-15 09:06:32 | Aoxing posts 3Q profit

2017-03-08 12:05:46 | Aoxing Pharmaceutical Co., Inc. :AXN-US: Earnings Analysis: Q2, 2017 By the Numbers : March 8, 2017

2017-02-17 12:34:43 | AOXING PHARMACEUTICAL COMPANY, INC. Files SEC form 10-Q/A, Quarterly Report

2017-02-14 17:41:44 | AOXING PHARMACEUTICAL COMPANY, INC. Files SEC form 10-Q, Quarterly Report

2016-11-14 17:07:40 | AOXING PHARMACEUTICAL COMPANY, INC. Files SEC form 10-Q, Quarterly Report

2016-10-17 21:17:00 | Aoxing Hits Another 52-Week Low AXN

2016-10-12 13:04:08 | AOXING PHARMACEUTICAL COMPANY, INC. Financials

2016-10-06 17:50:00 | Aoxing Pharmaceutical Reports 2016 Results AXN

2016-10-05 16:33:20 | AOXING PHARMACEUTICAL COMPANY, INC. Files SEC form 10-K, Annual Report

2016-09-29 13:14:00 | Aoxing Pharmaceutical Delays 10-K Filing AXN

2016-07-08 16:19:51 | Aoxing Pharmaceutical Co., Inc.: Price momentum supported by strong fundamentals

2016-06-30 11:29:19 | Aoxing Pharmaceutical Starts producing Tilidine Hydrochloride Tablets

2016-06-30 08:30:00 | Aoxing Pharma Commences Production of Tilidine Hydrochloride Tablets

2016-06-23 07:56:50 | AOXING PHARMACEUTICAL COMPANY, INC. Files SEC form 8-K, Submission of Matters to a Vote of Security Holders

2016-05-17 14:02:54 | Aoxing Pharmaceutical Co., Inc. :AXN-US: Earnings Analysis: Q3, 2016 By the Numbers

2016-05-16 08:00:00 | Aoxing Pharmaceutical Reports Q3 Fiscal 2016 Financial Results

2016-05-16 07:34:44 | Aoxing posts 3Q profit

2016-05-16 07:06:24 | AOXING PHARMACEUTICAL COMPANY, INC. Files SEC form 10-Q, Quarterly Report

2016-02-11 10:54:24 | Aoxing Pharmaceutical Co., Inc. Earnings Analysis: Q2, 2016 By the Numbers

2016-02-08 09:24:45 | Aoxing posts 2Q profit

2016-02-08 08:30:00 | Aoxing Pharmaceuticals Q2 Revenue Up 27%; Net Income $2.1 Million, Up 265%

2016-02-08 08:18:01 | AOXING PHARMACEUTICAL COMPANY, INC. Files SEC form 10-Q, Quarterly Report

2016-02-01 08:30:00 | Aoxing Pharma Appoints Dr. James Chen as Chief Financial Officer

2016-02-01 06:05:28 | AOXING PHARMACEUTICAL COMPANY, INC. Files SEC form 8-K, Financial Statements and Exhibits

2015-10-13 13:20:43 | Why Did These Stocks Move Higher On Tuesday And Should You Follow The Crowd?